HubSpot (NYSE:HUBS – Get Free Report) had its price objective hoisted by equities researchers at Canaccord Genuity Group from $710.00 to $900.00 in a report issued on Thursday,Benzinga reports. The ...

Fintel reports that on February 12, 2025, Canaccord Genuity upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) ...

Canaccord Genuity has downgraded Pliant (PLRX) to hold following news that the company has paused a clinical trial for its ...

George Gianarikas, Canaccord Genuity analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on Tesla.

In a report released today, Robert Young from Canaccord Genuity maintained a Buy rating on Dye & Durham (DND – Research Report), with a ...

Biogen (NASDAQ:BIIB – Get Free Report) had its target price lowered by equities researchers at Canaccord Genuity Group from ...

The surprise retirement of Dunelm's boss shouldn't put off investors from the homeware retailer's strong growth prospects, ...

Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief Financial Officer, will participate in a virtual ...

Canaccord Genuity analyst Susan Anderson maintained a Buy rating on Edgewell Personal Care (EPC – Research Report) yesterday and set a price ...

A big dividend yield for a few years doesn't mean much if it can't be sustained. While Canaccord Genuity Group is not profitable, it is paying out less than 75% of its free cash flow, which means that ...

Uncertainty around North American trade has hindered capital-markets activity and stalled investments in Canada, according to Canaccord Genuity Group Inc. Chief Executive Officer Daniel Daviau ...

Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.